首頁 > 市場調查報告書 > 醫療設備

美容整形

2028年神經毒素市場預測 - COVID-19影響和全球分析，按產品類型（肉毒素、Dysport、Xeomin和其他）、應用分類（治療和美容）和終端用戶（醫院、專科診所、皮膚科診所和其他）

市場調查報告書

商品編碼

1280735

2028年神經毒素市場預測 - COVID-19影響和全球分析，按產品類型（肉毒素、Dysport、Xeomin和其他）、應用分類（治療和美容）和終端用戶（醫院、專科診所、皮膚科診所和其他）

Neurotoxin Market Forecast to 2028 - Global Analysis By Product Type (Botox, Dysport, Xeomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)

出版日期: 2023年05月09日 | 出版商:

The Insight Partners | 英文 186 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

神經毒素的市場規模預計將從2022年的66.2236億美元達到2028年的131.9506億美元；估計從2023年到2028年將記錄12.3%的複合年成長率。

在預測期內，神經毒素的整體市場預計將成倍地推進，以滿足日益成長的臉部美容需求。 2022年3月，Aquavit Pharmaceuticals, Inc.宣布提交"DTX-021 "的新藥研究（IND） - 一種A型肉毒桿菌毒素，旨在治療中度至重度眼袋紋。該產品是一種高度純化並經過臨床測試的可注射的神經調節劑，其900 kDa的蛋白複合物來源於肉毒桿菌產生的神經毒素。另外，阿奎特公司正通過推出DTX-022加速臨床試驗，其最終批准將被公認為是同類產品中的第一種，也是世界上第一個泛臉部微注射神經毒素的產品。

同樣，隨著持續的減肥趨勢，胃部肉毒桿菌素已成為尋求非侵入性手術的患者的一個流行選擇。它涉及使用內視鏡技術將肉毒桿菌毒素注射到特定的胃部區域。通過這種技術，胃部肌肉的收縮受到了限制。由於這種限制，胃的排空過程需要更長的時間，這促使病人在更長的時間內有飽腹感，從而減少食慾，改善與體重有關的健康問題/生活方式障礙，如高血壓和糖尿病。

2021年6月，高德美宣布推出新產品- "Alluzience" - 旨在成為歐洲第一種即用型神經調節劑和一種皺紋舒緩注射劑。新推出的產品Alluzience是一種液體形式的A型肉毒桿菌毒素，特別適用於成年患者，可暫時改善中度至重度眼袋紋（眉間豎紋）的外觀。

根據產品類型，神經毒素市場被分類為肉毒素、dysport、xemoin和其他。肉毒素部分在2022年佔據了最大的市場佔有率，預計在預測期內將錄得最高的年復合成長率。肉毒桿菌毒素在醫療美容行業非常受歡迎。廣泛使用的肉毒桿菌毒素是A型肉毒桿菌。肉毒桿菌毒素市場主要受到審美意識提高和一些非侵入性美容程序的推動。此外，護理品質的提高，專業服務的改善，以及高素質的美容外科醫生提供的微創手術，都促進了程序量的成長，技術的進步，以及低成本的美容產品的推出。 2022年11月，韓國的一家醫療美容公司Hugel宣布其Letybo獲得了澳大利亞治療商品管理局（TGA）的批准。 Letybo是一種A型肉毒桿菌毒素注射劑，配方用於治療眼袋紋適應症。該公司計劃在2023年第一季度內完成其第一批貨物並在當地市場推出。

不同國家對品牌的偏好不同；例如，在新加坡主要使用的肉毒桿菌毒素品牌有Botox（Allergan）、Dysport（Ipsen Biopharmaceuticals Inc.）、Xeomin（Merz Pharmaceuticals, LLC）。這些都是健康儲蓄賬戶（HAS）批准的。這些品牌的價格為每單位肉毒桿菌20.6-34.4美元（15-25新加坡元），Dysport 16.5-27.5美元（12-20新加坡元），Xeomin 20.6-27.5美元（15-20新加坡元）。根據Evolus的估計，肉毒桿菌的市場佔有率最大，占到整個肉毒桿菌市場的70%。同樣，在泰國，有兩個主要品牌，即Botox Allergan和Botox Aestox，被廣泛使用並得到泰國FDA的批准。 Botox Allergan的價格為2802.8美元（79.98泰銖），Botox Aestox的單價為7008美元（199.98泰銖）。上述這些因素是2023-2028年期間神經毒素市場的細分成長的原因。

世界衛生組織（WHO）、美國疾病控制和預防中心（CDC）、英格蘭健康教育協會（HEE）、國家健康與護理卓越研究所（NICE）和治療用品管理局（TGA）是在編寫神經毒素市場報告時參考的幾個主要的主要和次要來源。

全球神經毒素市場收入預測和分析
全球神經毒素市場，按地域分類- 預測和分析
主要參與者的市場定位
注射美容手術的數量和美容手術部門的活躍醫生
按性別分類的日本、韓國和英國的臉部程序
美國的非手術程序，按性別身份分類
美國的非手術程序，按年齡組分類
美國的外科手術程序，按性別身份分類
美國的外科手術，按年齡組分類
英國的外科手術程序，按性別身份分類
德國的外科和非外科手術程序，按性別身份分類

第7章：全球神經毒素市場- 2028年的收入和預測- 按類型分類

概述
按類型分類，神經毒素市場收入佔有率（2022年和2028年）
肉毒桿菌素
迪斯波特
Xeomin
其他類型

第八章：全球神經毒素市場- 收入和預測到2028年- 按應用分類

概述
神經毒素市場收入佔有率，按應用分類（2022年和2028年）
治療性
審美

第九章：全球神經毒素市場- 收入和預測到2028年- 按終端用戶分類

概覽
神經毒素市場收入佔有率，按終端用戶分類（2022年和2028年）
醫院
醫療水療中心和美容中心
皮膚病診所
其他

第十章：神經毒素市場- 2028年的收入和預測- 地域分析

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 波蘭
- 俄羅斯
- 歐洲其他地區
亞太地區
- 澳大利亞
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 委內瑞拉
- 南美和中美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 黎巴嫩
- 中東和非洲其他地區

第十一章：COVID-19大流行對神經毒素市場的影響

北美洲：對COVID-19大流行的評估
歐洲
亞太地區
南美洲和中美洲
中東和非洲

第十二章：神經毒素市場-行業格局

概述
神經毒素市場的成長策略
有機成長戰略
- 概述
無機成長策略
- 概述

第十三章：公司簡介

Merz Pharma GmbH & Co KGaA
AbbVie Inc
Revance Therapeutics Inc
Ipsen SA
Medytox Inc
Evolus Inc
Hugel Inc
Lanzhou Institute of Biological Products Co Ltd
Gufic
Metabiologics

第十四章：附錄

關於洞察力合作夥伴
術語表

簡介目錄圖表

Product Code: TIPRE00013507

The neurotoxin market size is expected to reach US$ 13,195.06 million by 2028 from US$ 6,622.36 million in 2022; it is estimated to record a CAGR of 12.3% from 2023 to 2028.

The overall market for neurotoxins is expected to propel exponentially during the forecast period to meet the growing demand for facial aesthetics. In March 2022, Aquavit Pharmaceuticals, Inc. announced the submission of an Investigational New Drug (IND) of "DTX-021"-a botulinum toxin type A intended to treat moderate to severe glabellar lines. The product is a highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. Also, Aquavit is accelerating clinical trials by introducing DTX-022, and its final approval will be recognized as the first-of-its-kind and the world's first pan-facial microinjection of neurotoxins.

Likewise, with the ongoing weight loss trend, Gastric Botox has become a popular choice among patients seeking non-invasive procedures. It involves injecting Botox into specific stomach regions using an endoscopic technique. By this technique, the contraction of the stomach muscles is restrained. Due to the limitation, the stomach's evacuation process takes longer, which causes the patient to feel full for longer period, resulting in reduced appetite and improved weight-related health issues/lifestyle disorders such as high blood pressure and diabetes mellitus.

In June 2021, Galderma announced a new product launch-"Alluzience"-intended to be the first ready-to-use neuromodulator and a wrinkle-relaxing injection in Europe. The newly launched product Alluzience is a liquid form of botulinum toxin type A, particularly for adult patients, to temporarily improve the appearance of moderate to severe glabellar lines (vertical lines between the eyebrows).

Based on product type, the neurotoxin market is segmented into botox, dysport, xemoin, and others. The botox segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period.. Botulinum toxins are much popular in the medical aesthetic industry. The widely used botulinum toxin is Botulinum type A. The botulinum toxin market is primarily driven by rising aesthetic consciousness and a number of noninvasive cosmetic procedures. In addition, the increasing quality of care, improved professional services, and the availability of minimally invasive surgeries by highly qualified aesthetic surgeons have contributed to procedural volume growth, technological advancements, and the introduction of cost-effective aesthetic products. In November 2022, Hugel, a medical aesthetic company in South Korea, announced receiving approval from Australia's Therapeutic Goods Administration (TGA) for its Letybo. Letybo is a botulinum toxin type A injection formulated to treat glabellar lines indications. The company plans to complete its first shipment and launch in the local market within the first quarter of 2023.

The preference of the brands differs in different countries; for instance, botulinum toxin brands that are largely used in Singapore are Botox (Allergan), Dysport (Ipsen Biopharmaceuticals Inc.), Xeomin (Merz Pharmaceuticals, LLC). These are Health Saving Account (HAS) approved. The prices of these brands are Botox US$ 20.6-34.4 (Singapore$ 15-25), Dysport US$ 16.5-27.5 (Singapore$ 12-20), and Xeomin US$ 20.6-27.5 (Singapore$ 15-20) per unit. As per Evolus's estimates, Botox has the maximum market share that holds ~70% of the total botulinum toxin's market. Similarly, in Thailand, two main brands, Botox Allergan and Botox Aestox, are widely used and approved by the Thai FDA. Botox Allergan costs US$ 2,802.8 (79.98 baht) and Botox Aestox costs US$ 7,008 (199.98 baht) per unit. These aforementioned factors are responsible for the segmental growth of the neurotoxin market during 2023-2028.

The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), Health Education England (HEE), National Institute for Health and Care Excellence (NICE), and Therapeutic Goods Administration (TGA) are a few key primary and secondary sources referred to while preparing the report on the neurotoxin market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the neurotoxin market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global neurotoxin market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global neurotoxin market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Neurotoxin Market - by Type
- 1.3.2 Global Neurotoxin Market - by Application
- 1.3.3 Global Neurotoxin Market - by End User
- 1.3.4 Global Neurotoxin Market - by Geography

2. Neurotoxin Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Neurotoxin Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East and Africa PEST Analysis
- 4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion

5. Neurotoxin Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Surge in Cosmetic Procedures to Improve Appearance
- 5.1.2 Emergence of Innovative Facial Aesthetic Products
5.2 Market Restraints
- 5.2.1 Improper/Inappropriate Injection Technique
5.3 Market Opportunities
- 5.3.1 Neurotoxins to Reduce Spasticity in Upper Limb Muscles
5.4 Future Trends
- 5.4.1 BOTA for Assisted Reproductive Technology (ART)
5.5 Impact Analysis

6. Neurotoxin Market - Global Analysis

6.1 Global Neurotoxin Market Revenue Forecast and Analysis
6.2 Global Neurotoxin Market, by Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Number of Cosmetic Injectable Procedures and Active Physicians at Cosmetic Surgery Departments
6.5 Facial Procedures in Japan, South Korea, and the UK by Gender Identity
6.6 Non-surgical Procedures in the US, by Gender Identity
6.7 Non-surgical Procedures in the US, by Age Group
6.8 Surgical Procedures in the US, by Gender Identity
6.9 Surgical Procedures in the US, by Age Group
6.10 Surgical Procedures in the UK, by Gender Identity
6.11 Surgical and Non-surgical Procedures in Germany, by Gender Identity

7. Global Neurotoxin Market - Revenue and Forecast to 2028 - By Type

7.1 Overview
7.2 Neurotoxin Market Revenue Share, by Type (2022 and 2028)
7.3 Botox
- 7.3.1 Overview
- 7.3.2 Botox: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Dysport
- 7.4.1 Overview
- 7.4.2 Dysport: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Xeomin
- 7.5.1 Overview
- 7.5.2 Xeomin: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Neurotoxin Market - Revenue and Forecast to 2028 - By Application

8.1 Overview
8.2 Neurotoxin Market Revenue Share, by Application (2022 and 2028)
8.3 Therapeutic
- 8.3.1 Overview
- 8.3.2 Therapeutic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
- 8.4.1 Overview
- 8.4.2 Aesthetic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Neurotoxin Market - Revenue and Forecast to 2028 - By End User

9.1 Overview
9.2 Neurotoxin Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Medical Spas and Beauty Centers
- 9.4.1 Overview
- 9.4.2 Medical Spas and Beauty Centers: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Dermatology Clinics
- 9.5.1 Overview
- 9.5.2 Dermatology Clinics: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

10. Neurotoxin Market - Revenue and Forecast to 2028 - Geographic Analysis

10.1 North America: Neurotoxin Market
- 10.1.1 Overview
- 10.1.2 North America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.3 North America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.1.4 North America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.1.5 North America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.1.6 North America: Neurotoxin Market, by Country, 2022& 2028 (%)
  - 10.1.6.1 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.1.1 Overview
    - 10.1.6.1.2 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.1.3 US: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.6.1.4 US: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.6.1.5 US: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.1.6.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.2.1 Overview
    - 10.1.6.2.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.2.3 Canada: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.6.2.4 Canada: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.6.2.5 Canada: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.1.6.3 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.3.1 Overview
    - 10.1.6.3.2 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.3.3 Mexico: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.6.3.4 Mexico: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.6.3.5 Mexico: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2 Europe: Neurotoxin Market
- 10.2.1 Overview
- 10.2.2 Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.2.3 Europe: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.2.4 Europe: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.2.5 Europe: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.2.6 Europe: Neurotoxin Market, by Country, 2022 & 2028 (%)
  - 10.2.6.1 UK: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.1 Overview
    - 10.2.6.1.2 UK: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.3 UK: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.2.6.1.4 UK: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.2.6.1.5 UK: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.2.6.2 Germany: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.1 Overview
    - 10.2.6.2.2 Germany: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.3 Germany: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.2.6.2.4 Germany: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.2.6.2.5 Germany: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.2.6.3 France: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.1 Overview
    - 10.2.6.3.2 France: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.3 France: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.2.6.3.4 France: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.2.6.3.5 France: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.2.6.4 Italy: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.1 Overview
    - 10.2.6.4.2 Italy: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.3 Italy: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.2.6.4.4 Italy: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.2.6.4.5 Italy: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.2.6.5 Spain: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.1 Overview
    - 10.2.6.5.2 Spain: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.3 Spain: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.2.6.5.4 Spain: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.2.6.5.5 Spain: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.2.6.6 Poland: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.1 Overview
    - 10.2.6.6.2 Poland: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.3 Poland: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.2.6.6.4 Poland: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.2.6.6.5 Poland: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.2.6.7 Russia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.7.1 Overview
    - 10.2.6.7.2 Russia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.7.3 Russia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.2.6.7.4 Russia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.2.6.7.5 Russia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.2.6.8 Rest of Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.8.1 Overview
    - 10.2.6.8.2 Rest of Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.8.3 Rest of Europe: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.2.6.8.4 Rest of Europe: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.2.6.8.5 Rest of Europe: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3 Asia Pacific: Neurotoxin Market
- 10.3.1 Overview
- 10.3.2 Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.3.3 Asia Pacific: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.3.4 Asia Pacific: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.3.5 Asia Pacific: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.3.6 Asia Pacific: Neurotoxin Market, by Country, 2022 & 2028 (%)
  - 10.3.6.1 Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.1.1 Overview
    - 10.3.6.1.2 Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.1.3 Australia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.3.6.1.4 Australia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.1.5 Australia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.3.6.2 China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.2.1 Overview
    - 10.3.6.2.2 China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.2.3 China: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.3.6.2.4 China: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.2.5 China: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.3.6.3 India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.3.1 Overview
    - 10.3.6.3.2 India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.3.3 India: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.3.6.3.4 India: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.3.5 India: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.3.6.4 Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.4.1 Overview
    - 10.3.6.4.2 Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.4.3 Japan: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.3.6.4.4 Japan: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.4.5 Japan: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.3.6.5 South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.5.1 Overview
    - 10.3.6.5.2 South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.5.3 South Korea: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.3.6.5.4 South Korea: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.5.5 South Korea: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.3.6.6 Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.1 Overview
    - 10.3.6.6.2 Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.3 Rest of Asia Pacific: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.3.6.6.4 Rest of Asia Pacific: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.6.5 Rest of Asia Pacific: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.4 South and Central America: Neurotoxin Market
- 10.4.1 Overview
- 10.4.2 South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.4.3 South and Central America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.4.4 South and Central America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.4.5 South and Central America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.4.6 South and Central America: Neurotoxin Market, by Country, 2022 & 2028 (%)
  - 10.4.6.1 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.1.1 Overview
    - 10.4.6.1.2 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.1.3 Brazil: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.4.6.1.4 Brazil: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.4.6.1.5 Brazil: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.4.6.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.2.1 Overview
    - 10.4.6.2.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.2.3 Argentina: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.4.6.2.4 Argentina: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.4.6.2.5 Argentina: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.4.6.3 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.3.1 Overview
    - 10.4.6.3.2 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.3.3 Venezuela: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.4.6.3.4 Venezuela: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.4.6.3.5 Venezuela: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.4.6.4 Rest of South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.4.1 Overview
    - 10.4.6.4.2 Rest of South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.4.3 Rest of South and Central America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.4.6.4.4 Rest of South and Central America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.4.6.4.5 Rest of South and Central America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5 Middle East and Africa: Neurotoxin Market
- 10.5.1 Overview
- 10.5.2 Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
- 10.5.3 Middle East and Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
- 10.5.4 Middle East and Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
- 10.5.5 Middle East and Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
- 10.5.6 Middle East and Africa: Neurotoxin Market, by Country, 2022 & 2028 (%)
  - 10.5.6.1 South Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.1.1 Overview
    - 10.5.6.1.2 South Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.1.3 South Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.5.6.1.4 South Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.5.6.1.5 South Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.5.6.2 Saudi Arabia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.2.1 Overview
    - 10.5.6.2.2 Saudi Arabia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.2.3 Saudi Arabia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.5.6.2.4 Saudi Arabia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.5.6.2.5 Saudi Arabia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.5.6.3 UAE: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.3.1 Overview
    - 10.5.6.3.2 UAE: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.3.3 UAE: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.5.6.3.4 UAE: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.5.6.3.5 UAE: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.5.6.4 Israel: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.4.1 Overview
    - 10.5.6.4.2 Israel: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.4.3 Israel: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.5.6.4.4 Israel: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.5.6.4.5 Israel: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.5.6.5 Lebanon: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.5.1 Overview
    - 10.5.6.5.2 Lebanon: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.5.3 Lebanon: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.5.6.5.4 Lebanon: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.5.6.5.5 Lebanon: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.5.6.6 Rest of Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.6.1 Overview
    - 10.5.6.6.2 Rest of Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.6.3 Rest of Middle East and Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.5.6.6.4 Rest of Middle East and Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.5.6.6.5 Rest of Middle East and Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Neurotoxin Market

11.1 North America: Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Neurotoxins Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in Neurotoxins Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Merz Pharma GmbH & Co KGaA
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 AbbVie Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Revance Therapeutics Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Ipsen SA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Medytox Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Evolus Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 1SWOT Analysis
- 13.6.6 Key Developments
13.7 Hugel Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Lanzhou Institute of Biological Products Co Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Gufic
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Metabiologics
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Number of Cosmetic Injectable Procedures and Active Physicians at Cosmetic Surgery Departments, 2021
Table 2. Facial Procedures in Japan, South Korea, and the UK by Gender Identity, 2021
Table 3. Non-surgical Procedures in the US, by Gender Identity, 2021
Table 4. Non-surgical Procedures in the US, by Age Group, 2021
Table 5. Surgical Procedures in the US, by Gender Identity, 2021
Table 6. Surgical Procedures in the US, by Age Group, 2021
Table 7. Surgical Procedures in the UK, by Gender Identity, 2021
Table 8. Surgical and Non-surgical Procedures in Germany, by Gender Identity, 2021
Table 9. North America Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. North America Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. North America Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 12. US Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. US Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 14. US Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 17. Canada: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 24. UK Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 25. UK Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 26. UK Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 30. France: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 36. Spain: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 39. Poland: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 40. Poland: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 41. Poland: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 42. Russia: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 43. Russia: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 44. Russia: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Europe: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 46. Rest of Europe: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 47. Rest of Europe: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 49. Asia Pacific Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 50. Asia Pacific Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 52. Australia Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 53. Australia Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 54. China: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 55. China: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 56. China: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 57. India: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 58. India: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 59. India: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 60. Japan: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 61. Japan: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 62. Japan: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 63. South Korea: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 64. South Korea: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 65. South Korea: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of Asia Pacific: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Asia Pacific: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Asia Pacific: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 69. South and Central America Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 70. South and Central America Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 71. South and Central America Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 72. Brazil Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 73. Brazil Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 74. Brazil Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 75. Argentina: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 76. Argentina: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 77. Argentina: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 78. Venezuela: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 79. Venezuela: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 80. Venezuela: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of South and Central America: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 82. Rest of South and Central America: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 83. Rest of South and Central America: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 84. Middle East and Africa Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 85. Middle East and Africa Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 86. Middle East and Africa Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 87. South Africa Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 88. South Africa Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 89. South Africa Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 90. Saudi Arabia: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 91. Saudi Arabia: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 92. Saudi Arabia: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 93. UAE: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 94. UAE: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 95. UAE: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 96. Israel: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 97. Israel: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 98. Israel: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 99. Lebanon: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 100. Lebanon: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 101. Lebanon: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 102. Rest of Middle East and Africa: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 103. Rest of Middle East and Africa: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 104. Rest of Middle East and Africa: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 105. Recent Organic Growth Strategies in Neurotoxins Market
Table 106. Recent Inorganic Growth Strategies in the Neurotoxins Market
Table 107. Glossary of Terms

List Of Figures

Figure 1. Neurotoxin Market Segmentation
Figure 2. Neurotoxin Market by Region
Figure 3. Global Neurotoxin Market Overview
Figure 4. Botox Largest Share of Type Segment in Neurotoxin Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Neurotoxin Market, by Geography (US$ Million)
Figure 7. Global Neurotoxin Market - Leading Country Markets (US$ Million)
Figure 8. Global Neurotoxin Market - Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Neurotoxin Market: Impact Analysis of Drivers and Restraints
Figure 15. Global Neurotoxin Market - Revenue Forecast and Analysis - 2021-2028
Figure 16. Global Neurotoxin Market, by Geography - Forecast and Analysis (2022-2028)
Figure 17. Market Positioning of Key Players in the Neurotoxin Market
Figure 18. Neurotoxin Market Revenue Share, by Type (2022 and 2028)
Figure 19. Botox: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dysport: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Xeomin: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Neurotoxin Market Revenue Share, by Application (2022 and 2028)
Figure 24. Therapeutic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Aesthetic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Neurotoxin Market Revenue Share, by End User (2022 and 2028)
Figure 27. Hospitals: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Medical Spas and Beauty Centers: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Dermatology Clinics: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 32. North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 34. US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Europe: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 38. Europe Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Europe: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 40. UK: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Germany: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. France: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Italy: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Spain: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Poland: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Russia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Rest of Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Asia Pacific: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 49. Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Asia Pacific: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 51. Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 54. Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 57. South and Central America: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 58. South and Central America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 59. South and Central America: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 60. Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 61. Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 62. Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 63. Rest of South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Middle East and Africa: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 65. Middle East and Africa Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 66. Middle East and Africa: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 67. South Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. Saudi Arabia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 69. UAE: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. Israel: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 71. Lebanon: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 72. Rest of Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 73. Impact of COVID-19 Pandemic on North American Country Markets
Figure 74. Impact of COVID-19 Pandemic on European Country Markets
Figure 75. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
Figure 76. Impact of COVID-19 Pandemic on South and Central America Country Markets
Figure 77. Impact of COVID-19 Pandemic on Middle East and Africa Country Markets
Figure 78. Growth Strategies in Neurotoxins Market